Patents by Inventor Cory Theberge

Cory Theberge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV PROTEASE INHIBITORS
    Publication number: 20100093811
    Abstract: Compounds of Formula I are disclosed: (I), wherein XA, k, R1, R2, R3, R4, R5, R5A, R6, R6A, R7 and R8 are defined herein. The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be metabolized in vivo to HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: September 22, 2008
    Publication date: April 15, 2010
    Inventors: Craig A. Coburn, Joseph P. Vacca, Hemaka A. Rajapakse, Kristen L.G. Jones, Philippe Nantermet, James C. Barrow, Keith P. Moore, Steven S. Sharik, Cory Theberge, Abbas M. Walji
  • Bicyclic Anilide Spirolactam Cgrp Receptor Antagonists
    Publication number: 20080096878
    Abstract: The present invention is directed to compounds of Formula (I): (where variables A1, A2, B, J, K, m, n, R4, R5a, R5b and R5c are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    Type: Application
    Filed: September 9, 2005
    Publication date: April 24, 2008
    Inventors: Ian Bell, Cory Theberge, Craig Stump, Xufang Zhang, Steven Gallicchio, C.Blair Zartman
  • Aryl Spirolactam Cgrp Receptor Antagonists
    Publication number: 20080004304
    Abstract: The present invention is directed to compounds of Formula (I): where variables A1, A2, B, J, K, m, n, R4, R5a, R5a, R5c and X are as defined herein useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    Type: Application
    Filed: September 6, 2005
    Publication date: January 3, 2008
    Inventors: Ian Bell, Craig Stump, Cory Theberge
  • Bicyclic anilide spirohydantoin cgrp receptor antagonists
    Publication number: 20060211712
    Abstract: The present invention is directed to compounds of the formula: that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    Type: Application
    Filed: March 10, 2004
    Publication date: September 21, 2006
    Inventors: Ian Bell, Steven Gallicchio, Cory Theberge, Xu-Fang Zhang, Craig Stump, C. Zartman
  • Aryl spirohydantoin cgrp receptor antagonists
    Publication number: 20060189593
    Abstract: The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    Type: Application
    Filed: March 10, 2004
    Publication date: August 24, 2006
    Inventors: Ian Bell, Cory Theberge, Xu-Fang Zhang, C. Blair Zartman
  • Monocyclic anilide spirohydantoin cgrp receptor antagonists
    Publication number: 20060148779
    Abstract: The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    Type: Application
    Filed: March 10, 2004
    Publication date: July 6, 2006
    Inventors: Ian Bell, Cory Theberge, Theresa Williams, C. Blair Zartman, Xu-Fang Zhang, Steven Gallicchio